(1888PressRelease)
September 22, 2007 - Babette "Babs" Clough, a local advanced practitioner of homeopathy, has improved alternative healthcare services through the use of what many are calling the latest bio-technology from ZYTO Corp.
ZYTO Corp. (Pink Sheets: ZYTC) provides the technology that has been used by a rapidly growing number of healthcare practitioners who say it enables them to make better clinical decisions, and does it in a way that helps them to serve more people in a shorter period of time.
“The use of ZYTO technology has made it easier for me to assist more people in my practice, and more accurately determine how to help them on the road to better health,” explained Clough, who is offering free demonstrations of the technology to the media and the general public.
Optimal Health Associates and Pain Management Center is located at 1750 Locust Street, Suite A in Reno. Appointments can be made by calling 775-284-4700.
ZYTO Corp. has seen rapid growth over the past year as more and more healthcare practitioners discover this new patent pending technology.
“Our body is talking to us. For example, our stomach tells us that it is hungry, or pain from our finger tells us when we have a cut. Our body parts are constantly sending and receiving signals that we can use to learn to take better care of our own health. ZYTO technology enables computers to receive those signals so healthcare practitioners can make more informed choices,” explained Dr. Vaughn R. Cook, OMD, president and founder of ZYTO Corp.
ZYTO Corp. has a web site at http://www.ZYTO.com and Clough offers information at http://www.OHAssociates.com
About ZYTO Corp.
ZYTO Corp. was founded by Dr. Vaughn Cook, OMD. The company provides computerized bio-technology equipment and software with clinical applications that include obtaining information from the human body to assist healthcare practitioners to make better decisions.
Forward Looking Statement:
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports the Company may file.
Press Contact:
David M. Bresnahan
801-224-7199
